Outlook Therapeutics, Inc. Investor Rights Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Investor Rights Agreement between Outlook Therapeutics, Inc. and GMS Ventures and Investments (April 21, 2022)
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2022
Fourth Amendment to Investor Rights Agreement among Outlook Therapeutics, BioLexis Pte. Ltd., and GMS Ventures and Investments
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020
Third Amendment to Investor Rights Agreement between Oncobiologics, Inc. and BioLexis Pte. Limited
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2018
Second Amendment to Investor Rights Agreement between Oncobiologics, Inc. and GMS Tenshi Holdings Pte. Limited
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2018
Amendment to Investor Rights Agreement between Oncobiologics, Inc. and GMS Tenshi Holdings Pte. Limited (May 11, 2018)
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2018
Investor Rights Agreement between Oncobiologics, Inc. and GMS Tenshi Holdings Pte. Limited (September 11, 2017)
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2017
Investors’ Rights Agreement among Oncobiologics, Inc., Strides Pharma Inc., and Certain Key Holders (March 10, 2014)
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016
Investors’ Rights Agreement among Oncobiologics, Inc., Strides Pharma Inc., and Certain Key Holders (March 10, 2014)
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016
Investors’ Rights Agreement among Oncobiologics, Inc., Strides Pharma Inc., and Certain Key Holders (March 10, 2014)
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016